Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
57.24
+1.16 (2.07%)
Aug 7, 2026, 11:49 AM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $358.08 billion as of August 7, 2026. Its market cap has increased by 41.13% in one year.
Market Cap
358.08B
Enterprise Value
392.05B
Revenue
77.92B
Ranking
n/a
PE Ratio
23.44
Stock Price
$57.24
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 358.08B, an increase of 3,988.31%. That is a compound annual growth rate of 11.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 358.08B | 8.01% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 536.36M |
| Silence Therapeutics | 530.91M |
| Veradigm | 523.16M |
| Elite Pharmaceuticals | 393.03M |
| American Oncology Network | 337.32M |
| Northwest Biotherapeutics | 271.78M |
| CytoDyn | 256.81M |
| Comjoyful International Company | 211.51M |